Sex Differences in Outcome After Endovascular Stroke Therapy for Acute Ischemic Stroke

Author:

Sheth Sunil A.1,Lee Songmi1,Warach Steven J.2,Gralla Jan3,Jahan Reza4,Goyal Mayank5,Nogueira Raul G.6,Zaidat Osama O.7,Pereira Vitor M.8,Siddiqui Adnan9,Lutsep Helmi10,Liebeskind David S.11,McCullough Louise D.1,Saver Jeffrey L.11

Affiliation:

1. From the Department of Neurology, McGovern School of Medicine, University of Texas Health Science Center at Houston (S.A.S., S.L., L.D.M.)

2. Department of Neurology, Dell School of Medicine, University of Texas at Austin (S.J.W.)

3. Department of Neuroradiology, Inselspital, University Hospital, Berne, Switzerland (J.G.)

4. Department of Radiological Sciences, Ronald Reagan UCLA Medical Center, Santa Monica (R.J.)

5. Department of Radiology and Clinical Neurosciences, University of Calgary, AB, Canada (M.G.)

6. Department of Neurology, Emory School of Medicine, Atlanta, GA (R.G.N.)

7. Department of Neurosurgery, Mercy Health, Toledo, OH (O.O.Z.)

8. Department of Medical Imaging, Toronto Western Hospital, ON, Canada (V.M.P.)

9. Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, NY (A.S.)

10. Department of Neurology, Oregon Health and Science University, Portland (H.L.).

11. Department of Neurology, Ronald Reagan UCLA Medical Center, Santa Monica (D.S.L., J.L.S.)

Abstract

Background and Purpose— We determined the effect of sex on outcome after endovascular stroke thrombectomy in acute ischemic stroke, including lifelong disability outcomes. Methods— We analyzed patients treated with the Solitaire stent retriever in the combined SWIFT (Solitaire FR With the Intention for Thrombectomy), STAR (Solitaire FR Thrombectomy for Acute Revascularization), and SWIFT PRIME (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment) cohorts. Ordinal and logistic regression were used to examine known factors influencing outcome after endovascular stroke thrombectomy and study the effect of sex on the association between these factors and outcomes, including age and time to reperfusion. Years of optimal life after thrombectomy were defined as disability-adjusted life years and calculated by projecting disability through adjusted poststroke life expectancy by sex. Results— Among 389 patients treated with endovascular stroke thrombectomy, 55% were females, and median National Institutes of Health Stroke Scale was 17 (interquartile range, 8–28). There were no differences between females versus males in presenting deficit severity (National Institutes of Health Stroke Scale score, 17 versus 17, P =0.21), occlusion location (69% versus 64% M1, P =0.62), presenting infarct extent (Alberta Stroke Program Early CT Score 8 versus 8, P =0.24), rate of substantial reperfusion (Thrombolysis in Cerebral Infarction 2b/3, 87% versus 83%, P =0.37), onset to reperfusion time (294 versus 302 minutes, P =0.46). Despite older ages (69 versus 64, P <0.001) and higher rate of atrial fibrillation (45% versus 30%, P =0.002) for females compared with males, adjusted rates of functional independence at 90 days were similar (odds ratio, 1.0; 95% CI, 0.6–1.6). After adjusting for age at presentation and stroke severity, females had more years of optimal life (disability-adjusted life year) after endovascular stroke thrombectomy, 10.6 versus 8.5 years ( P <0.001). Conclusions— Despite greater age and higher rate of atrial fibrillation, females experienced comparable functional outcomes and greater years of optimal life after intervention compared with males.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3